Suppression or elevation of cytosolic phospholipase A2 alters keratinocyte prostaglandin synthesis, growth, and apoptosis

Cancer Research

Volumn 58, Issue 20, 1998, Pages 4624-4631

  Lo, Herng Hsiang ^a   Teichmann, Peter ^b   Fürstenberger, Gerhard ^b   Gimenez Conti, Irma ^a   Fischer, Susan M ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; COMPLEMENTARY DNA; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOLIPASE A2; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; RNA; TRITIUM;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; KERATINOCYTE; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; SKIN CARCINOMA; TUMOR GROWTH;

ANIMALS; APOPTOSIS; CELL DIVISION; CYTOSOL; DINOPROSTONE; FEMALE; KERATINOCYTES; MICE; PHOSPHOLIPASES A; RNA, MESSENGER; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0032532392     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Fischer, S. M. Eicosanoids and Tumor Promotion. In: H. Muhktar (ed.), Skin Cancer: Mechanisms and Human Relevance, pp. 129-144. Boca Raton, FL: CRC Press, Inc., 1995.
2. Verma, A. K., Rice, H. M., and Boutwell, R. K. Prostaglandins and skin tumor promotion: inhibition of tumor-promoter induced ornithine decarboxylase activity in epidermis by inhibitors of prostaglandin synthesis. Biochem. Biophys. Res. Commun., 79: 1160-1166, 1977.
3. 2 inhibitors and lipoxygenase inhibitor. Cancer Res., 42: 2841-2845, 1982.
4. Uzumaki, H., Yamamoto, S., and Kato, R. Effects of lipoxygenase and cycloxygenase inhibitors on the induction of omithine decarboxylase by 12-O-tetradecanoylphorbol-13-acetate and isoproterenol in mouse tissue in vivo. Carcinogenesis (Lond.), 7: 289-294, 1986.
5. Nakadate, T., Yamamoto, S., Aizu, E., and Kato, R. Inhibition of 12-CMetradecanoylphorbol-13-acetate-induced increase in vascular permeability in mouse skin by lipoxygenase inhibitors. Jpn. J. Pharmacol., 38: 161-168, 1985.
6. Fischer, S. M., Patrick, K. E., Patamali, B., and Slaga, T. J. Effects of antihistamines on phorbol ester tumor promotion and vascular permeability changes. Carcinogenesis (Lond.), 11: 991-996, 1990.
7. Tiano, H., Chulada, P., Spalding, J., Lee, C., Loftin, C., Mahler, J., Morham, S., and Langenbach, R. Effects of cyclooxygenase deficiency on inflammation and papilloma development in mouse skin. Proc. Am. Assoc. Cancer Res., 38: 257, 1997.
8. Chulada, P., Doyle, C., Gaul, B., Tiano, H., Mahler, J., Lee, C., Morham, S., and Langenbach, R. Cyclooxygenase-1 and -2 deficiency decrease spontaneous intestinal adenoma in Min mouse. Proc. Am. Assoc. Cancer Res., 39: 195, 1998.
9. Tsujii, M., and DuBois, R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin synthase-2. Cell, 83: 493-501, 1995.
10. Sheng, H., Shao, J., Kirkland, S. C., Isakson, P., Coffey, R. J., Morrow, J., Beauchamp, R. D., and DuBois, R. N. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J. Clin. Invest., 99: 2254-2259, 1997.
11. Müller-Decker, K., Scholz, K., Marks, F., and Fürstenberger, G. Differential expression of prostaglandin H synthase isozymes during multistage carcinogenesis in mouse epidermis. Mol. Carcinog., 12: 31-41, 1995.
12. 2(S): comparison of arachidonyl-selective and -nonselective enzymes. FASEB J., 7: 339-348, 1993.
13. 2. J. Biol. Chem., 269: 13057-13060, 1994.
14. 2 by bradykinin and 4β-phorbol 12-myristate 13-acetate. Eur. J. Biochem., 202: 941-950, 1991.
15. 2). J. Invest. Dermatol., 101: 567-572, 1993.
16. Balmain, A., Krumlauf, R., Vass, J. K., and Birnie, G. D. Cloning and characterization of the abundant cytoplasmic 7S RNA from mouse cells. Nucleic Acids Res., 10: 203-207, 1982.
17. 2 is coupled to hormonally regulated release of arachidonic acid. Proc. Natl. Acad. Sci. USA, 89: 6147-6151, 1992.
18. Belury, M. A., Locniskar, M., and Fischer, S. M. Modulation of phorbol ester-associated events in epidermal cells by linoleate and arachidonate. Lipids, 28: 407-413, 1993.
19. Homung, J., Bohnert, A., Phan-Than, L., Krieg, T., and Fusenig, N. E. Basement membrane formation by malignant mouse keratinocyte cell lines in organotypic culture and transplants: correlation with degree of morphologic differentiation. J. Cancer Res. Clin. Oncol., 113: 325-341, 1987.
20. 2 analogue on normal hairless mouse epidermal DNA synthesis. J. Invest. Dermatol., 68: 134-137, 1977.
21. Fürstenberger, G., Gross, M., and Marks, F. Involvement of prostaglandins in the process of skin tumor promotion. In: H. Thaler-Dao, A. Graste de Paulet, and R. Paoletti (eds.), Icosanoids and Cancer, pp. 91-100. New York: Raven Press, 1984.
22. Fürstenberger, G., and Marks, F. The role of eicosanoids in normal, hyperplastic and neoplastic growth in mouse skin. In: T. Ruzicka (ed.), Eicosanoids and the Skin, pp. 108-124. Boca Raton, FL: CRC Press, Inc., 1990.
23. Stern, M. C., Duran, H. A., McKenna, E. A. E., and Conti, C. J. Apoptosis increases with papilloma development in mice susceptible to tumor progression. Mol. Carcinog., 20: 137-142, 1997.
24. Maldve, R., and Fischer, S. M. Multifactor regulation of prostaglandin H synthase-2 in murine keratinocytes. Mol. Carcinog., 17: 207-216, 1996.
25. 2 in mouse epidermal keratinocytes. J. Lipid Res., 39: 569-582, 1998.
26. 2 by transforming growth factor-α in HEL-30 keratinocytes. J. Biol. Chem., 268: 16795-16802, 1993.
27. 2 activity is not accompanied by reduced arachidonic acid release. Biochem. Biophys. Res. Commun., 1: 220-227, 1994.
28. 2 by antisense and effects on endotoxin-induced prostaglandin biosynthesis. J. Biol. Chem., 269: 25999-26005, 1994.
29. Capriotti, A. M., Furth, E. E., Arrasmith, M. E., and Laposata, M. Arachidonate release upon agonist stimulation preferentially originates from arachidonate most recently incorporated into nuclear membrane phospholipids. J. Biol. Chem., 263: 10029-10034, 1988.
30. Fischer, S. M., Baldwin, J. K., Jasheway, D. W., Patrick, K. E., and Cameron, G. S. Phorbol ester induction of the 8-lipoxygenase in inbred SENCAR (SSIN) but not C57B1/6J mice correlated with hyperplasia, edema and oxidant generation but not ornithine decarboxylase induction. Cancer Res., 48: 658-664, 1988.
31. Pentland, A. P., and Needleman, P. J. Modulation of keratinocyte proliferation in vitro by endogenous prostaglandins. J. Clin. Invest., 77: 246-251, 1986.
32. Qiao, L., Konzoni, V., Tsioulias, G. J., Koutsos, M. I., Hanif, R., Shiff, S. J., and Rigas, B. Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo. Biochim. Biophys. Acta, 1258: 215-223, 1995.
33. Fürstenberger, G., Gross, M., Schweizer, J., Vogt, I., and Marks, F. Isolation, characterization, and cultivation of subfractions of neonatal mouse keratinocytes: effects of phorbol esters. Carcinogenesis (Lond.), 7: 1745-1753, 1986.
34. Pasricha, P. J., Bedi, A., O'Connor, K., Rashid, A., Akhtar, A. J., Zahurak, M. L., Piantadosi, S., Hamilton, S. R., and Giardello, F. M. The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology, 109: 994-998, 1995.
35. Lu, X., Xie, W., Reed, D., Bradshaw, W. S., and Simmons, D. L. Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenase in chicken embryo fibroblasts. Proc. Natl. Acad. Sci. USA, 92: 7961-7965, 1995.
36. Chan, T. A., Morin, P. J., Vogelstein, B., and Kinzler, K. W. Mechanisms underlying nonsteroidal anti-inflammatory drug-mediated apoptosis. Proc. Natl. Acad. Sci. USA, 95: 681-688, 1998.
37. Tang, D. W. Guan, K-L., Li, L., Honn, K. V., Chen, Y. Q., Rice, R. L., Taylor, J. D., and Porter, A. T. Suppression of W256 carcinosarcoma cell apoptosis by arachidonic acid and other polyunsaturated fatty acids. Int. J. Cancer, 72: 1078-1087, 1997.
38. 2 production by macrophages infected with HIV. Cell Immunol., 152: 120-130, 1993.
39. 2-activating protein in endothelial cells. Biochem. J., 250: 125-132, 1988.
40. 2 in human heptocarcinoma SK-HEP-1 cells. FEBS Lett., 369: 348-352, 1995.
41. Conney, A. H., Lou, Y. R., Xie, J. G., Osawa, T., Newmark, H. L., Liu, Y., Chang, R. L., and Huang, M. T. Some perspectives on dietary inhibition of carcinogenesis studies with curcumin and tea. Proc. Soc. Exp. Biol. Med., 216: 234-245, 1997.
42. Fischer, S. M., Gleason, G. L., Hardin, L. G., Bohrman, J. S., and Slaga, T. J. Prostaglandin modulation of phorbol ester skin tumor promotion. Carcinogenesis (Lond.), 1: 245-248, 1980.
43. Du, M., Singh, N., Husseuin, A., Isaacson, P. G., and Pan, L. Positive correlation between apoptotic and proliferative indices in gastrointestinal lymphomas of mucosa-associated lymphoid tissue (MALT). J. Pathol., 178: 379-384, 1996.
44. Kuwashima, Y., Uehara, T., Kurosumi, M., Sniromizu, K., Matzusawa, M., and Kishi, K. Cell dynamics of undifferentiated carcinomas of the ovary. Immunohistochemical estimation of their growth fraction and apoptotic status. Eur. J. Oncol., 16: 268-273, 1995.
45. Gaffny, E. F. The extent of apoptosis in different types of high grade prostatic carcinoma. Histopathology, 25: 269-273, 1994.